BioHaven’s Troriluzole Fails Co-Primary Endpoints in Phase 2 Trial for Mild-to-Moderate Alzheimer’s Disease
BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase […]
BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase […]
Just over a year ago, TrialSite introduced the exploits of the fake principal investigator named Sani Anwar, owner of Zain […]
A large health care workers union has recently made very serious allegations against a major U.S. health care company. Specifically, […]
Levo Therapeutics announced top-line results from the Phase 3 CARE-PWS clinical study evaluating LV-101 (intranasal carbetocin) for the treatment of Prader-Willi Syndrome (PWS). […]
Lundbeck announced a decision to discontinue a phase II proof of concept clinical study of Lu AF11167 in patients with schizophrenia who are […]
Genentech announced topline results from its Phase III study program evaluating the etrolizumab in patients with moderate to severely active ulcerative […]
The World Health Organization’s Solidarity Trial covering COVID-19 launches in Gujarat India at sites including SVP College in Ahmedabad, GMERs, […]
A federal civil lawsuit has been filed against a state agency and several officials alleging a conspiracy to silence complaints about […]
The University of Iowa (UI) generates $467 million in external research funding for research—reaching an all-time high for the academic […]
Moffit Cancer Center CEO Dr. Alan List is purportedly leaving the institution due a violation of the cancer center’s rules […]